Susquehanna International Group, LLP Cor Medix Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Cor Medix Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 322,350 shares of CRMD stock, worth $4.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
322,350
Previous 26,727
1106.08%
Holding current value
$4.35 Million
Previous $216,000
818.98%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding CRMD
# of Institutions
148Shares Held
22.7MCall Options Held
475KPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.65MShares$49.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$47.9 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl2.44MShares$33 Million0.1% of portfolio
-
State Street Corp Boston, MA1.54MShares$20.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.43MShares$19.3 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $555M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...